With increased pressure on costs, competition, and regulation, the healthcare environment is undergoing constant change. PWW’s longstanding focus, continuous research, and collective expertise in the Pharma and Biotech sector has consistently supported our client partners’ strategic goals in developing and maintaining dependable market strategies to create market gains, commercialize revolutionary new treatments, and optimize approaches to promote existing drug therapies.
If your business is considering Competitive Intelligence to drive your organization’s growth, Proactive Worldwide’s Healthcare & Life Sciences team has the business, industry, and scientific expertise to provide the contextual insight and perspective to optimize your business decisions. As a leading practitioner in Pharma Competitive monitoring, Traditional Pharmaceutical Competitive and Market Intelligence services, and Conference/Social Media monitoring, we can help your business plan for and achieve your strategic objectives. Our Healthcare and Life Sciences Competitive Intelligence Consulting services include but are not limited to:
- competitive monitoring of all aspects of pharmaceutical product development from R&D through lifecycle management strategies;
- tracking and analysis of competing manufacturers’ drug approvals and drug launch dates in real time;
- medical conference monitoring, including all planning and post-conference reporting;
- using double-blinded key opinion leader interviews or direct participation/presentation to advisory boards;
- assessment of potential investment and M&A opportunities;
- evaluating current salesforce structure, approach and conversion rates
Solving these multi-dimensional market research and primary intelligence challenges to gain strategic insights is what PWW’s HCLS practice does best, with global multi-disciplinary leadership and analyst teams that include Ph.D. and MBA-level talent. Our HCLS practice leaders have a proven track record of enhancing business value across industry and intelligence market segments and business functions for CI Managers, Brand Managers, and Market Researchers alike, which results in enabling top-level decision makers to make sense of where your enterprise stands and navigate your success more confidently within the Pharma and Biotech space.
As with PWW’s Medical Devices and Healthcare and Pharmacy Systems consulting services, our ultimate goal is to help drive your business growth with best-practice, strategic insight decision and forecasting support system. For more information on our subscription-based MedForecast® drug approval tracking service, the first of its kind to offer real-time data collection, integrative analytics and Bayesian inference modeling to yield exceptionally accurate drug approval and launch predictions, please visit MedForecastpro.com.
PWW Cross-segment experience:
- Biotechnology / Life Sciences
- Biosimilar Entry and Defense
- Health Plans / Insurance / PBM / Specialty Pharmacy / ACA
- Market Access Strategies
- Pharmaceuticals (LCM, Rx to OTC)
- Medical Devices
- Oncology and Hematology
- Pain and Inflammation
- Central Nervous System
- Infectious Diseases
- Cardiovascular/Metabolic Endocrine and Diabetes
- Respiratory Diseases Gastroenterological Disease